The FDA has granted approval to CooperVision’s MiSight single-use contacts for slowing the progression of myopia in children.
The device, approved using the premarket approval pathway, is a disposable, soft contact lens that is indicated for slowing progression of nearsightedness in children aged 8 to 12.
The lens corrects the refractive error that impacts distance vision, similar to a standard corrective lens, and using peripheral rings in the lens to focus light on the back of the eye, which is believed to reduce progression of the condition.
